Search Tag: clinical-stage biotechnology
Kineta Appoints Keith Baker as Chief Financial Officer
2022 04 Oct
Kineta, Inc, a clinical-stage biotechnology company focused on the development of novel immunotherapies in oncology announced the appointment of Keith Baker as the Company’s new Chief Financial Officer (CFO). “It is a pleasure to welcome Keith to our management team at this pivotal time for Kineta,” said Shawn Iadonato, Ph.D., Chief Executive Officer... Read more
Cardiff Oncology Announces Departure of Chief Medical Officer
2022 12 Apr
Cardiff Oncology, Inc., a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers has announced that Katherine L. Ruffner , M.D., chief medical officer (CMO), will be leaving the Company on April 22, 2022 , to pursue a new opportunity. Dr. Ruffner will provide Cardiff Oncology with transitional... Read more